959
Views
1
CrossRef citations to date
0
Altmetric
Letter to the editor

Reply: Re: Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson’s Disease in the UK and Germany

&
Pages 860-862 | Accepted 14 Jul 2015, Published online: 27 Jul 2015
 

Transparency

Declaration of funding

No funding declared for this Letter.

Declaration of financial/other relationships

E.W., P.O have previously received lecture fees from EVER Neuro Pharma.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.